Jasper Therapeutics, Inc. announced the appointment of healthcare industry veteran Vishal Kapoor, Partner of Avego Management, as a Class I director of the Company. Mr. Kapoor, age 47 has been a Partner of Avego Management, LLC, an affiliate of Velan Capital, since January 2021, leading their life sciences venture investing strategy. He was also President of Amplitude Healthcare Acquisition Corporation, a life sciences focused special purpose acquisition company, until its merger with Jasper Therapeutics in September 2021.

Prior to that, Mr. Kapoor was Chief Business Officer of Iveric bio (formerly known as Ophthotech). At Iveric, he was responsible for acquiring an portfolio of gene therapy and therapeutic assets in ophthalmology. Prior to Iveric, Mr. Kapoor was Director of Corporate Development at NPS Pharmaceuticals, Inc., which Shire acquired in 2015 for $5.2 billion.

Before NPS, Mr. Kapoor spent nine years at Genentech in various positions, including leading strategy for ophthalmology and central nervous system pipeline assets, Lucentis marketing, commercial assessments for business development, and medical affairs. In addition, Mr. Kapoor has previously worked at Pfizer. Mr. Kapoor holds an MBA in Finance and Management from Columbia Business School and a BA in Biology from Columbia University.